James Edward Doyle - 08 Jun 2023 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Director
Signature
/s/ James Edward Doyle by Mark R. Busch, attorney-in-fact
Issuer symbol
EXAS
Transactions as of
08 Jun 2023
Net transactions value
-$126,895
Form type
4
Filing time
12 Jun 2023, 16:29:21 UTC
Previous filing
31 May 2023
Next filing
28 Jul 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Award $0 +3,599 +6.9% $0.000000 55,512 08 Jun 2023 Direct F1
transaction EXAS Common Stock Sale $126,895 -1,402 -2.5% $90.51 54,110 09 Jun 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy.
F2 The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into on February 24, 2023.